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Summary
Background: Cells release extracellular vesicles (ECVs) that
can influence differentiation, modulate the immune response,
promote coagulation, and induce metastasis. Many ECVs
form by budding outwards from the plasma membrane, but
the molecules that regulate budding are unknown. In ECVs,
the outer leaflet of the membrane bilayer contains amino-
phospholipids that are normally sequestered to the inner
leaflet of the plasma membrane, suggesting a role for lipid
asymmetry in ECV budding.
Results: We show that loss of the conserved P4-ATPase
TAT-5 causes the large-scale shedding of ECVs and disrupts
cell adhesion and morphogenesis in Caenorhabditis elegans
embryos. TAT-5 localizes to the plasma membrane and its
loss results in phosphatidylethanolamine exposure on cell
surfaces. We show that RAB-11 and endosomal sorting
complex required for transport (ESCRT) proteins, which regu-
late the topologically analogous process of viral budding, are
enriched at the plasma membrane in tat-5 embryos, and are
required for ECV production.
Conclusions: TAT-5 is the first protein identified to regulate
ECV budding. TAT-5 provides a potential molecular link
between loss of phosphatidylethanolamine asymmetry and
the dynamic budding of vesicles from the plasma mem-
brane, supporting the hypothesis that lipid asymmetry regu-
lates budding. Our results also suggest that viral bud-
ding and ECV budding may share common molecular
mechanisms.
Introduction
Extracellular vesicles (ECV) can act as messengers between
cells. For example, ECVs can influence developmental
fates by delivering morphogens such as Hedgehog [1].
ECVs released by platelets induce coagulation and can
activate an immune response [2, 3]. Tumor cells release
ECVs that promote metastasis, and infectious viral particles
co-opt ECV biogenesis machinery to spread. ECVs form
through two major routes. One pathway is via the direct
budding of plasma membrane to form ECVs known as micro-
particles, microvesicles, or ectosomes. Alternatively, ECVs
called exosomes form when multivesicular bodies fuse with
the plasma membrane, releasing their intralumenal vesicles*Correspondence: jeremy.nance@med.nyu.eduoutside of the cell. Whereas the mechanisms responsible
for exosome production are better understood, the molecular
mechanisms that lead to ectosome budding remain a
mystery.
Because the outer surfaces of ectosomes expose atypi-
cally high levels of the aminophospholipids phosphatidyl-
serine (PS) and phosphatidylethanolamine (PE), it has been
proposed that lipid externalization could facilitate ectosome
formation on the plasma membrane [4]. PS and PE are nor-
mally asymmetrically enriched in the inner leaflet of the
membrane bilayer. These lipids have conical shapes that
can bend membranes, and PS is an anionic lipid that contrib-
utes to the negative charge of the membrane [5]. Interest-
ingly, activated platelets from Scott syndrome patients
cannot externalize PS or PE and fail to release ECVs to induce
coagulation [6], supporting a potential link between loss of
lipid asymmetry and ECV budding.
Lipid asymmetry is mediated by transmembrane flippases
from the P4 family of ATPases, which internalize phospho-
lipids by translocating them from the outer to the inner leaflet
of the bilayer [7]. PS translocase activity was definitively
proven for yeast Drs2p and human ATP8B2 [8, 9]. Mutations
in each of the five S. cerevisiae P4-ATPases cause defects
in vesicle biogenesis or transport [10]. Humans have 14 P4-
ATPases, many of which are uncharacterized, but mutations
in the PS flippase ATP8B1 cause intrahepatic cholestasis [7].
Hepatocytes progressively lose microvilli and ATP8B1 is
implicated in maintaining membrane integrity [11]. Despite
the potential connection between disrupted lipid asymmetry
and ectosome production, no P4-ATPase has been shown to
inhibit ectosome formation.
A link between lipid flipping and cellular phenotype has also
been established in Caenorhabditis elegans, which contains
six P4-ATPases (TAT-1 to TAT-6) [12]. The Drs2p homolog
TAT-1 is required to prevent PS exposure and thereby regu-
lates cell corpse engulfment [13, 14]. TAT-1 has also been
implicated in lysosome biogenesis and endocytosis [15, 16].
TAT-2, TAT-3, and TAT-4 regulate sterol or branched chain
fatty acid metabolism through mechanisms that have not yet
been established [12, 17]. The Neo1p homolog TAT-5 is the
sole essential P4-ATPase in C. elegans, but its role has not
yet been determined.
Here, we identify TAT-5 for its requirement during morpho-
genesis in the C. elegans embryo. We show that TAT-5 local-
izes to the plasma membrane and is needed to prevent PE
exposure. Loss of TAT-5 causes the large-scale budding of
vesicles from the plasma membrane, compromising cell
adhesion and leading to defects in cell shape. We show
that the robust production of ECVs depends on RAB-11,
a GTPase associated with recycling endosomes; and the
endosomal sorting complex required for transport (ESCRT)
proteins, which form multivesicular bodies. These proteins
are enriched at the plasma membrane in tat-5 embryos
and are known to regulate the budding of viruses from the
plasma membrane [18, 19]. Our findings identify the first
P4-ATPase that inhibits ECV budding, providing a link
between PE asymmetry, regulators of viral budding, and
ECV biogenesis.
Figure 1. TAT-5 Is Required for Cell Shape Changes and Gastrulation
(A and B) Stills of 28-cell embryos from differential interference contrast
(DIC) movies. E indicates endodermal precursors ingressing in control but
not tat-5 embryos.
(C andD) Endodermal precursors express end-1::GFP::CAAXduring gastru-
lation in 26-cell embryos. P granules (red) localize to the germ cell precursor.
(E and F) Stills of late 4-cell embryos from DIC movies. Arrowheads point to
the anterior edge of EMS, which extends under ABa in control but not tat-5
embryos.
(G and H) Stills of devitellinized late 4-cell embryos from DIC movies. Cells
appear more rounded in tat-5 embryos as denoted by contour lines. All
images lateral views with anterior to the left and dorsal up. Scale bar repre-
sents 15 mm.
See also Figure S1, Movie S1, and Movie S2.
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TAT-5 Is Needed for Robust Cell Adhesion and Dynamic
Changes in Cell Shape
We identified TAT-5 in an RNA interference (RNAi) screen for
essential genes important for morphogenesis in C. elegans
embryos. Morphogenesis begins at gastrulation when the
endodermal precursors flatten their apical surfaces and
ingress into the center of the embryo (Figure 1A; see also
Movie S1 available online) [20]. In tat-5(RNAi) embryos, the
endodermal precursors remained rounded and failed to
ingress (Figure 1B; Movie S1), even though they expressed
endoderm-specific markers (Figures 1C and 1D) and showed
characteristic cell cycle lengths. Therefore, ingression defects
in tat-5(RNAi) embryos did not result from a defect in
specification.To confirm the specificity of tat-5 RNAi, we examined
embryos in two uncharacterized deletions that remove
portions of tat-5 (tm1741 and tm1772). TAT-5 contains an
ATPase domain and ten transmembrane domains. Both
deletions remove part of the ATPase domain and the third
transmembrane domain and are predicted to create frame-
shifts that eliminate the remainder of the protein. Over 95%
of tat-5 mutants were sterile (n = 179), but rare worms
produced a few embryos with rounded cells that invariably
died (Figure S1B) like tat-5(RNAi) embryos. Because tat-
5(RNAi) and tat-5 mutant embryos have indistinguishable
phenotypes, hereafter we use RNAi for phenotypic analysis
of tat-5. Mutations or RNAi that target the other P4-ATPases
did not cause lethality [12] or disrupt cell shape (data not
shown). Thus, TAT-5, but not other P4-ATPases, is required
for the cell shape changes and movements that occur during
gastrulation.
Because similar defects are observed in embryos lacking
the adhesion proteins HMR-1/E-cadherin and SAX-7/L1CAM
[21], we investigated whether tat-5 embryos have defects in
cell adhesion. In wild-type 4-cell embryos, the ventral cell
EMS extends an adhesive protrusion along the anterior cell
ABa (Figure 1E; Movie S1). By contrast, EMS remained
rounded and did not protrude in tat-5 embryos (Figure 1F).
When we removed the confining eggshell, it was evident that
all tat-5 cells were rounded in comparison towild-type (Figures
1G and 1H; Movie S2). There was a significant increase in cell
circularity in tat-5 embryos, and the length of cell-cell contacts
was reduced (see Supplemental Experimental Procedures).
Cells in tat-5 embryos were also easily dissociated during
devitellinization (14/30 embryos), in contrast to wild-type
(1/23 embryos). However, loss of TAT-5 does not disrupt
morphogenesis by preventing the localization of HMR-1 and
SAX-7 to cell contacts (Figures S1C–S1F). Thus, cell adhesion
is weakened in tat-5 mutant embryos through a novel mecha-
nism, and poor adhesion may explain the observed defects
in cell shape and morphogenesis.
Extracellular Tubulovesicular Structures Accumulate
in tat-5 Embryos
We next asked whether tat-5 embryos had defects in the orga-
nization of the plasma membrane that could disrupt cell adhe-
sion. Using a reporter (PHPLC1v1::mCherry) that localizes to the
plasmamembrane, we observed patches of increased labeling
in tat-5 embryos (Figure 2B) compared to wild-type embryos
(Figure 2A). Similarly increased membrane labeling was
observed in embryos from tat-5 deletion mutants (Figure S2D)
and also with transmembrane proteins such as HMR-1 and
SAX-7 (Figures S1D and S1F). This phenotype suggests that
tat-5 embryos accumulate extra membrane on the surfaces
of cells, which could disrupt cell contacts.
To reveal the nature of the extramembrane in tat-5 embryos,
we performed an ultrastructural analysis using transmission
electron microscopy (TEM). Cell-cell contacts in control
embryos were evident as a pair of 5 nm thick plasma mem-
branes that were rarely separated (Figure 2C). In tat-5
embryos, the plasma membranes were separated by a gap
up to 300 nm in thickness, which contained numerous extra-
cellular vesicles or tubules (Figure 2D). Hereafter, we refer to
these heterogeneous structures as ECVs. ECVs were also
present on the surface of 1-cell tat-5 embryos (Figure 2F) but
were rare in wild-type embryos (Figure 2E). We conclude that
the extra labeling with PHPLC1v1::mCherry in tat-5 em-
bryos corresponds to the ECVs we observe by TEM. We
Figure 2. Extracellular Vesicles Are Present on Cell Surfaces and between
Cell-Cell Contacts in tat-5 Embryos
(A and B) PHPLC1v1::mCherry in 4-cell embryos. Arrowheads point to thick
patches of membrane in tat-5 embryos. Scale bar represents 15 mm.
(C and D) Transmission electron micrograph (TEM) of the cell contact from
2-cell embryos. Black and white arrowheads point to the plasmamembrane
of different cells.
(E and F) TEM of the surface of 1-cell embryos. Arrows point to extracellular
vesicles or tubules. Scale bars in (C)–(F) represent 200 nm.
See Figure S2 for additional TEMs.
Figure 3. Extracellular Vesicles Are Generated by Budding from the Plasma
Membrane
(A) Model based on a TEM tomogram depicting the range in vesicle (arrow-
head) and tubulovesicle (arrow) shapes found in a 2-cell tat-5 embryo. Each
color represents a distinct structure and only membranes are traced.
(A0) Box from (A) depicting a vesicle (shaded) connected to the plasma
membrane. See also Movie S3 for vesicle shapes.
(B) Histogram of vesicle diameters from tat-5 intralumenal multivesicular
body (MVB) vesicles (light gray) averaging 65 6 15 nm, n = 110 from three
embryos, and extracellular vesicles (dark gray) averaging 149 6 35 nm,
n = 89 extracellular vesicles (ECVs) from three embryos.
(C and D) GFP::ZF1::SYX-4 (green) in 26-cell embryos. Dotted lines trace
cells where ZF1 degradation has occurred. In insets, SAX-7 (red) labels
the plasma membrane. Nuclei are blue.
(E and F) Surface view of 26-cell embryos expressing med-1::GFP::CAAX.
Oval outlines embryos. Arrowheads point to membrane thickening.
See Figure S3 for exosome marker data.
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1953hypothesize that these membrane structures interrupt the
contacts between cells and are responsible for the weakened
cell adhesion we observe in tat-5 embryos.
To demonstrate that the ECVs were vesicles not villi, we
used electron tomography to generate three-dimensional
reconstructions of the cell surface. In tat-5 embryos, we found
spherical vesicles, cup-shaped vesicles, and large tubulove-
sicular structures (Figure 3A; Movie S3). Most ECVs within a
200 nm section did not connect to the plasma membrane
and therefore are unlikely to be villi or intercellular bridges.
To confirm that most ECVs were outside the cell, we asked
whether proteins on the ECV membrane or their contents
were protected from degradation. When proteins tagged
with the PIE-1 ZF1 domain are expressed in the early embryo,
they are rapidly degraded in somatic cells [22]. We tagged the
integral plasma membrane protein SYX-4/syntaxin with the
ZF1 domain and GFP to assess its ability to be degraded in
tat-5 embryos. In wild-type embryos, GFP::ZF1::SYX-4 initially
localized to the plasma membrane but was rapidly endocy-
tosed and degraded as somatic cells formed (Figure 3C).
In tat-5 embryos, GFP::ZF1::SYX-4 was internalized and
degraded over much of the surface of somatic cells butremained within thickened patches that costained with SAX-7
(Figure 3D). We observed a similar pattern of protection when
ZF1-tagging the cortical proteins PAR-3 and PAR-6 in tat-5
embryos (data not shown). These findings suggest that ECVs
protect ZF1-tagged proteins from degradation because they
are not connected to the cell, supporting the tomography data.
Extracellular Vesicles in tat-5 Embryos Form by Plasma
Membrane Budding
We next analyzed whether the ECVs in tat-5 embryos
were exosomes or ectosomes. Exosomes are 40–100 nm
diameter vesicles derived from the intralumenal vesicles of
Figure 4. TAT-5 Localizes to the Plasma Membrane and Maintains Phosphatidylethanolamine Asymmetry
(A and B) GFP::TAT-5 (A) and GFP::TAT-5(E246Q) (B) expression in 2-cell embryos.
(C andD) GFP::TAT-5 (C) rescues (n = 164 embryos) andGFP::TAT-5(E246Q) (D) fails to rescue (n = 28 embryos)membrane thickenings (arrowhead) in 15-cell
embryos from tat-5(tm1741) mothers.
(E–G) Annexin V staining in 8- to 16-cell devitellinized embryos.
(H) Graph of normalized Annexin V membrane labeling intensity (control: n = 20 embryos, tat-1: n = 14, tat-5: n = 14).
(I–K) Duramycin staining in 44- to 46-cell devitellinized embryos. Arrowhead marks a cell contact.
(L) Graph of normalized duramycin membrane labeling intensity (control: n = 15 embryos, tat-1: n = 12, tat-5: n = 7).
Data are represented as mean 6 standard deviation (SD). Asterisks mark a significant difference compared to control: *p < 0.05, **p < 0.01.
See Figure S4 for GFP::TAT-5(D439E) localization and overall phospholipid content.
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1954multivesicular bodies (MVBs) [3]. To determine whether ECVs
in tat-5 embryos are exosomes, we compared the diameter
of ECVs and intralumenal MVB vesicles. The ECVs were signif-
icantly larger than intralumenal vesicles in tat-5 embryos (p <
10240), with little overlap (Figure 3B). Rare ECVs in wild-type
embryos were also larger than wild-type intralumenal vesicles
(ECV: 218 6 62 nm, n = 20 from five embryos; MVB: 57 6
16 nm, n = 106 from three embryos, p < 1029). Additionally,
we never observed MVBs fusing with the plasma membrane
in tomograms from tat-5 embryos (over 40 mm of cell contact
examined). The simple shapes of exosomes [3] are also incon-
sistent with the complicated tubulovesicular structures we
observed in tat-5 ECVs (Figure 3A). Finally, tat-5 ECVs did
not label with LMP-1/LAMP1 (Figure S3), a marker of exo-
somes in other systems [2]. Thus, we can find no evidence
that the ECVs derive from MVBs.
We next tested whether ECVs formed through the direct
budding of the plasma membrane as ectosomes. Ectosomes
are larger than exosomes (100–1,000 nm), consistent with
the observed size range of ECVs, and tend to have more irreg-
ular shapes [3]. We also observed 36 vesicles in tat-5 embryos
(in 40 mm of cell contact) that were connected to the plasma
membrane (Figure 3A0). We never observed a vesicle attached
to the plasma membrane in tomograms from wild-type
embryos (in 24 mm examined) and cannot conclude whether
the ECVs from wild-type and tat-5 embryos are equivalent.The labeling of ECVs with plasma membrane markers such
as PHPLC1v1::mCherry, GFP::ZF1::SYX-4, HMR-1, and SAX-7
is also consistent with a cell surface origin (Figures 2B and
3D; Figures S1D and S1F). Together, our observations suggest
that most or all ECVs in tat-5 embryos are ectosomes that
form by plasma membrane budding.
ECVs Are Formed throughout Embryogenesis
To determine whether ECVs are made continuously, we used
a reporter that would mark new but not preexisting ECVs. The
med-1::GFP::CAAX transgene is expressed in a subset of cells
after the 7-cell stage and labels the cytoplasmic face of the
membrane. In control embryos, GFP::CAAX labeled the plas-
ma membrane and thin filopodia-like protrusions (Figure 3E).
In tat-5 embryos, GFP::CAAX accumulated in large patches
on the surface of cells (Figure 3F). These observations suggest
that early embryonic cells produce ECVs continuously.
TAT-5 Localizes to the Plasma Membrane
To determine whether TAT-5 functions where ectosomes
are produced, we expressed a GFP-tagged transgene.
GFP::TAT-5 is functional and can rescue the sterility of tat-5
deletion alleles (>60% fertile, n = 61 adults, 2 transgenes). In
early embryos, GFP::TAT-5 was found primarily at the plasma
membrane but also labeled some cytoplasmic vesicles
(Figure 4A). GFP::TAT-5 also rescued the extra membrane
Figure 5. Clathrin, RAB-11, and the ESCRT Complex Are Recruited to the
Plasma Membrane in tat-5 Embryos
(A and B) GFP::CHC-1 (clathrin) in 4-cell embryos. Arrowhead indicates cell
contact.
(C and D) GFP::RAB-11 in 4-cell embryos. Bright spot is midbody.
(E and F) GFP::MVB-12 (ESCRT-I) in 4-cell embryos from vps-4 feeding
RNA interference (fRNAi) and tat-5 + vps-4 double-stranded RNA (dsRNA)
injections.
(G and H) Projections of 2-cell embryos stained for ESCRT-III protein
VPS-32 (green) from vps-4 fRNAi or tat-5 + vps-4 dsRNA injections (vps-4:
0.27 6 0.11 puncta/mm, n = 7, 136 mm examined; tat-5 + vps-4: 0.62 6
0.16 puncta/mm, n = 4, 97 mm examined; p < 0.01). PAR-3 (red) marks cell
cortex.
See Figure S5 for more endosomal markers.
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1955observed in tat-5 embryos (Figure 4C). The localization of
GFP::TAT-5 to the plasma membrane is consistent with
TAT-5 acting on the cell surface.
The ATPase activity of P4-ATPases is required for their lipid
flippase action [8]. To determine whether ATPase activity is
required for TAT-5 to prevent plasma membrane budding,
we mutated two sites essential for activity of P-type
ATPases: the aspartyl phosphorylation site (D439) or the motif
required for dephosphorylation of D439 [23]. GFP::TAT-
5(D439E) did not localize to the plasma membrane (Figures
S4A–S4D), whereas GFP::TAT-5(E246Q) localized to the
plasma membrane (Figure 4B) but failed to rescue the sterility
and maternal-effect embryonic lethality of tat-5 mutants (n =
120 adults, 2 transgenes). GFP::TAT-5(E246Q) localized tomembrane thickenings in embryos from tat-5 mutants (Fig-
ure 4D), demonstrating that TAT-5 ATPase activity is required
to prevent ECV formation.
TAT-5 Is Required to Prevent Cell Surface Exposure of PE
Ectosomes have been associated with high levels of external-
ized PS and PE [4]. As a P4-ATPase, TAT-5 is predicted
to regulate the bilayer asymmetry of one or more amino-
phospholipids. To establish whether PS asymmetry was
altered in tat-5 embryos, we stained the surface of unpermea-
bilized embryos with Annexin V, a protein that specifically
recognizes PS [24]. In control embryos, Annexin V labeled
the plasma membrane and endocytosed puncta weakly
(Figures 4E and 4H). In tat-1 mutants, embryonic cells stained
brightly with Annexin V (Figures 4F and 4H), consistent with
reports that PS was exposed on the surface of tat-1 germ cells
[13]. In tat-5 embryos, we observed weak labeling similar to
control embryos, even at regions where ectosomes accumu-
late (Figures 4G and 4H). We conclude that TAT-5 is not
required to prevent cell surface exposure of PS (in contrast
to TAT-1), and we find no evidence that ectosomes in tat-5
mutants externalized PS.
To analyze PE asymmetry, we used duramycin, which
specifically binds PE [25]. In cultured cells, PE is externalized
during cytokinetic furrow ingression [26]. Consistent with
these observations, duramycin stained a subset of cell con-
tacts in unpermeabilized wild-type embryos (Figure 4I), and
staining was similar in tat-1 embryos (Figure 4J). However, in
tat-5 embryos, duramycin staining was more uniform around
the plasma membrane and brightly labeled membrane thick-
enings (Figure 4K). The intensity of membrane staining, both
at regions with and without patches of ectosomes, was sig-
nificantly higher in tat-5 embryos than in control embryos
(Figure 4L, p < 0.01). Increased surface PE was not due to
a generally higher level of PE in tat-5 mutants, because levels
of PE and other phospholipids were equivalent in wild-type
and tat-5 (Figures S4E–S4F). These findings indicate that PE
is inappropriately externalized on tat-5 embryonic cells.
Clathrin, RAB-11, and the ESCRT Complex Are Enriched
at the Plasma Membrane in tat-5 Embryos
Given the unusual vesicles and mislocalized lipids in tat-5
embryos, we examined whether endocytosis and secretion
were disrupted.We found no evidence for a defect in secretion
using transgenes expressing secreted proteins (Figures S5A–
S5D), and markers for clathrin-dependent endocytosis were
normal in tat-5 (Figures S5C–S5F). We also found no defect
in the localization of early endosomal, late endosomal, Golgi,
or endoplasmic reticulum markers in tat-5 embryos (Figures
S5G–S5N), although lysosomes appeared enlarged (Figures
S3A and S3B; Figures S5O and S5P). Thus, loss of TAT-5
does not grossly disrupt membrane trafficking.
TAT-5 ortholog Neo1p has been linked to clathrin recruit-
ment in yeast [27], so we examined clathrin localization using
a tagged heavy-chain subunit (CHC-1) [28]. In control em-
bryos, GFP::CHC-1 was rapidly lost from the plasma mem-
brane after fertilization and was mostly cytoplasmic by the
4-cell stage (Figure 5A). In 4-cell tat-5 embryos, GFP::CHC-1
was still enriched at the plasma membrane (Figure 5B).
However, given that clathrin-mediated endocytosis was not
defective in tat-5 embryos (Figures S5E and S5F), the enrich-
ment of clathrin at the plasma membrane suggests
that clathrin recruitment or dissociation is aberrant in tat-5
embryos.
Figure 6. RAB-11 and the ESCRT Complex Mediate Extracellular Vesicle Production
(A and B) Graphs displaying percentage of embryos 6 SD with wild-type membranes, or mild or severe thickenings. Thickenings were judged mild if
they only affected a subset of 3-cell junctions or severe if they affected 2- and 3-cell junctions. Asterisks mark a significant difference compared to
tat-5: *p < 0.05, **p < 0.01.
(C–H) Embryos expressing PHPLC1v1::GFP from adults injected with the indicated dsRNAs.
See Figure S6 for controls and Table S1 for n values.
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proteins linked to viral shedding, which is provocative because
viral particles can also form by plasma membrane budding.
The small GTPase Rab11 is a regulator of recycling endo-
somes that is required for viral budding [18]. In control
embryos, GFP::RAB-11 had a punctate distribution in the
cytoplasm and on the cortex (Figure 5C). In tat-5 embryos,
GFP::RAB-11 became continuous along the plasma mem-
brane and had the same thickened appearance as other
membrane markers (Figure 5D). The recycling endosome
protein RME-1 showed a similar distribution (data not shown).
Thus, recycling endosome markers are over-recruited to the
plasma membrane or trapped in ECVs.
The ESCRT complex, which forms the intralumenal vesicles
of MVBs, is also required for viral shedding [19]. Because
ESCRT proteins do not stably associate with membranes
unless the ESCRT recycling protein VPS-4 is inhibited [29],
we examined the localization of early and late ESCRT proteins
in vps-4(RNAi) embryos. Proteins from the ESCRT-I (MVB-12)
and ESCRT-III (VPS-32) complexes stably labeled MVBs as
well as a small number of puncta on the plasma membrane
of vps-4 embryos (Figures 5E and 5G). In embryos from
tat-5 + vps-4 double-stranded RNA (dsRNA) injections, we
observed twice as many ESCRT-III puncta on the plasma
membrane, and ESCRT-I proteins were similarly enriched
(Figures 5F and 5H). ESCRT-III proteins do not label the plasma
membrane in tat-5 embryos when VPS-4 is present, suggest-
ing that ESCRT-III is not trapped within ectosomes (data notshown). These findings demonstrate that the ESCRT complex
is recruited to the plasma membrane in tat-5 embryos.
RAB-11 and the ESCRT Complex Are Required
for Ectosome Formation
Although externalized PE is predicted to promote outward
curvature of the plasma membrane, PE exposure is unlikely
to form complete vesicles without the assistance of proteins
[5]. Given that viral budding regulators RAB-11 and the ESCRT
complex were enriched at the plasma membrane in tat-5
embryos, we asked whether reducing their levels could
suppress the thickened membrane phenotype (Figures 6A
and 6B; Table S1). In embryos from tat-5 dsRNA injected
adults, we found that 82% had severe membrane thickening
(Figure 6D) compared to wild-type (Figure 6C). However,
when we coinjected rab-11 and tat-5 dsRNA, embryos more
closely resembled rab-11 single injections with only 11% of
embryos showing the severe thickening typical of tat-5 (Fig-
ure 6E). We verified that our double injections effectively tar-
geted tat-5 by injecting the GFP::TAT-5 strain (Figure S6).
In addition, RNAi targeting clathrin adaptors AP1 at the Golgi
(aps-1) or AP2 at the plasma membrane (aps-2) did not
suppress tat-5 membrane thickening (Figure 6A), demon-
strating that clathrin is unlikely to have a role in budding
ectosomes and that suppression by RAB-11 is specific. These
findings suggest that ectosomes arise from a RAB-11-depen-
dent membrane pool or through a RAB-11-dependent process
(see Discussion).
Figure 7. Two Models for the Role of TAT-5 and PE Externalization in
Ectosome Production
(A and B) TAT-5 normally internalizes phosphatidylethanolamine (PE). PE
externalization by an unknown scramblase could lead to the recruitment
or stabilization of the ESCRT complex to the plasma membrane, where
the ESCRT complex buds out ectosomes. RAB-11 could deliver proteins
needed for budding to the plasma membrane or could have a more direct
role in the budding process.
(A) Externalized PE results in microdomains of increased negative charge at
the cytoplasmic face (from relatively increased phosphatidylserine and
phosphatidylinositols density).
(B) Externalized PE induces domains of negative membrane curvature that
could act as hinge regions. These models are not exclusive.
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1957Next, we examined a role for the ESCRT complex in ecto-
some formation. The ESCRT complex is broken into four sub-
complexes: ESCRT-0 clusters cargo and recruits ESCRT-I,
ESCRT-I and ESCRT-II form membrane buds, and ESCRT-III
causes vesicle scission and release [19]. We found that
dsRNA targeting ESCRT-0 or ESCRT-I complex members
were able to partially suppress tat-5 membrane thickening
(Figure 6B; Table S1). For example, only 33% of embryos
from tat-5 + hgrs-1 (ESCRT-0) injections and 40% of embryos
from tat-5 + vps-28 (ESCRT-I) injections showed severe
membrane thickening (Figures 6F and 6G). Targeting ESCRT-
II, ESCRT-III (Figure 6H), or associated factors VPS-4 and
ALX-1 did not significantly suppress membrane thickenings,
although these proteins could be involved in ectosome release
rather than bud formation (see Discussion). Thus, these
suppression and localization data suggest that ESCRT
complex proteins are recruited to the plasma membrane in
tat-5 embryos and are required to bud vesicles out of the cell.Discussion
Impact of Cell Surface Organization on Morphogenesis
The lethality of tat-5 embryos highlights the importance of
proper surface membrane structure for cell shape changes
and morphogenesis. We propose that the accumulation of
intercellular ectosomes in tat-5 embryos compromises
morphogenesis by disrupting adhesion. For example, anterior
spreading of the EMS cell and endodermal cell ingression do
not occur in tat-5 embryos, and both of these events involve
the formation of adhesive cellular protrusions [30, 31].
Although similar morphogenetic defects can arise from im-
proper cell specification, specification occurs normally in
tat-5 early embryos.
Plasma Membrane Aminophospholipids
and Ectosome Formation
PS and PE are externalized on ectosomes, and it was
proposed that their externalization induces ectosome forma-
tion [4]. Our system allows us to test the potential contribu-
tions of PS and PE separately because of the specific effects
tat-1 and tat-5mutants have on lipid localization. PS asymme-
try was not disrupted on the plasma membrane or on ecto-
somes in tat-5 embryos. Additionally, despite the dramatic
externalization of PS in tat-1mutants, they do not accumulate
excess surface membrane (our unpublished data). Therefore,
although PS externalization has important signaling roles
[32], PS externalization is neither necessary nor sufficient for
ectosome formation. Although TAT-5 could regulate additional
lipids, the physical characteristics of PE (described below)
support the hypothesis that the loss of PE asymmetry induces
ectosome budding.
A Model for Ectosome Formation
TAT-5 is the first protein shown to repress both PE externaliza-
tion and ectosome production and provides a potential link
between these events. PE externalization occurs slowly unless
induced by lipid scramblases, which abolish lipid asymmetry
[32].Wepredict that TAT-5 opposes the action of a scramblase
to maintain PE asymmetry and inhibit ectosome formation
(Figure 7). Patients with Scott syndrome, whose platelets fail
to release ECVs [6], were found to carrymutations in a potential
scramblase [33], further correlating loss of lipid asymmetry
and ECV production. This raises the possibility that human
P4-ATPases (such as TAT-5 homologs ATP9A/B) may regulate
ECV formation and coagulation in platelets.
PE is an abundant, zwitterionic lipid with a small head group
and conical shape [5], and we can envision both indirect
and direct roles for PE in budding (Figures 7A and 7B). First,
PE externalization could alter the local charge of the plasma
membrane by increasing the density of sparser lipids in the
inner leaflet, such as anionic PS and phosphatidylinositols
(PI), resulting in the formation of anionic microdomains.
Anionic microdomains could recruit or stabilize membrane-
sculpting proteins that promote ectosome formation (Fig-
ure 7A). For example, mammalian Hrs (ESCRT-0) binds anionic
lipids [19]. We observed that HGRS-1/Hrs was required for
efficient ectosome production, and ESCRT proteins were en-
riched at the cell surface in tat-5 embryos. Clathrin, which
was similarly enriched at the cell surface in tat-5 embryos,
can also bind to anionic lipids or be recruited by Hrs [19, 34].
A second potential mechanism by which externalized PE
could lead to ectosome budding is through the formation of
PE-richmicrodomains within the outer leaflet. Because of PE’s
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to induce negative membrane curvature (Figure 7B). Indeed,
PE-rich microdomains that contain membrane-localized
ESCRT proteins have been implicated in HIV budding [35].
RAB-11 and the ESCRT Complex in Ectosome Production
Our suppression studies indicate that RAB-11 has an impor-
tant role in ectosome production. Both recycling endosome
markers we examined showed plasma membrane accumula-
tion in tat-5 embryos, raising the possibility that RAB-11-
dependent recycling of lipids or proteins to the plasma
membrane may be necessary for ectosome production. One
possibility is that RAB-11 delivers the ESCRT complex to the
plasma membrane. Alternatively, RAB-11 may have a direct
role in promoting ectosome budding, as has been suggested
for viral budding [18]. RAB-11 also promotes exosome
production [3], suggesting that ectosomes and exosomes
may be regulated by common pathways despite their distinct
subcellular origins.
The ESCRT proteins are well known for their role in forming
viral particles, but only recently have they been implicated in
ectosome budding [36]. HIV-1 budding requires ESCRT-I,
ESCRT-III, ALIX, and VPS4. The viral Gag protein recruits
ESCRT-I in place of ESCRT-0 [19]. We found that inhibiting
ESCRT-0 or ESCRT-I suppressed ECV formation in tat-5
embryos, but surprisingly, inhibiting ESCRT-III, ALX-1, or
VPS-4 did not. However, we believe that ESCRT-III is likely to
take part based on its recruitment to the plasma membrane
in tat-5 embryos. Given that the ESCRT-III complex is required
for scission, lack of suppression might reflect our inability to
distinguish stalled buds from released ectosomes by light
microscopy. By contrast, reducing ESCRT-0/I should prevent
bud formation early, and therefore reduce buildup of excess
membrane. Notably, inhibiting ESCRT-0/I proteins only
partially suppressed ectosome production in tat-5 embryos.
Although this may reflect partial knockdown, another possi-
bility is that ESCRT proteins regulate the production of
a subset of ectosomes. Indeed, a VPS4-independent mecha-
nism for viral budding has recently been identified, and this
budding is dependent on a Rab11-binding protein [37].
The Cellular Role of TAT-5 Homologs
The role of the TAT-5 subfamily of P4-ATPases has not been
examined in other multicellular organisms, but studies in yeast
suggest that some aspects of TAT-5 function may be
conserved. For example, although yeast Neo1p localizes
predominantly to endomembranes and Golgi, neo1 mutants
have ultrastructural phenotypes such as the formation of
unusual tubular and multivesicular structures [38, 39].
Because the intralumenal vesicles of MVBs share the same
topology as ectosomes, this phenotype could reflect an
analogous role for Neo1p in inhibiting the outward budding
of endosomal membranes. It will be important to determine
whether yeast and mammalian TAT-5 homologs have a similar
role in maintaining PE asymmetry and to test whether they can
influence the release of ectosomes or the budding of viral
particles from cells.
Experimental Procedures
Wormswere grown at 25Cunless stated otherwise. Time-lapse, differential
interference contrast (DIC), and fluorescent images were acquired and
processed as described [40, 41]. Extended Experimental Procedures are
available in the Supplemental Information.Supplemental Information
Supplemental Information includes six figures, one table, Supplemental
Experimental Procedures, and three movies and can be found with this
article online at doi:10.1016/j.cub.2011.10.040.
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